Fostering Research Training and Education Programs for Native American Students at NCI-designated Cancer Centers (Admin Supp)

The summary for the Fostering Research Training and Education Programs for Native American Students at NCI-designated Cancer Centers (Admin Supp) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Fostering Research Training and Education Programs for Native American Students at NCI-designated Cancer Centers (Admin Supp): The National Cancer Institute (NCI) is committed to reducing cancer related health disparities that affect all health disparity and underserved populations in the United States and to supporting research education, training and capacity building within, and near these communities. The NCI established the Center to Reduce Cancer Health Disparities (CRCHD) to strengthen cancer research by: addressing cancer health disparities; advising on strategic priorities, program direction, and scientific policy to strengthen cancer disparities research and training; and leading NCIs efforts to enhance scientific workforce diversity through the training of students and investigators from underrepresented backgrounds.

Federal Grant Title:	Fostering Research Training and Education Programs for Native American Students at NCI-designated Cancer Centers (Admin Supp)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-17-241
Type of Funding:	Grant
CFDA Numbers:	93.397
CFDA Descriptions:	Information not provided
Current Application Deadline:	April 28th, 2017
Original Application Deadline:	April 28th, 2017
Posted Date:	March 30th, 2017
Creation Date:	March 30th, 2017
Archive Date:	June 3rd, 2017
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	March 30th, 2017

Applicants Eligible for this Grant: Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See FOA for full eligibility details.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-17-241.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial...; • Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Com...; • Administrative Supplements to Cancer Center Support Grants to Strengthen the Research, Tra...; • Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Com...; • Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...